Stina Singel

Stina Singel

Chief Tech/Sci/R&D Officer at ASCENDIS PHARMA A/S

Net worth: - $ as of 31/05/2026

53 year
Health Technology
Consumer Services

Profile

Currently, Stina Singel is Executive VP & Head-Clinical Development at Ascendis Pharma A since 2023.
Formerly, Dr. Singel was SVP, Head-Clinical Development & Drug Safety at Nektar Therapeutics from 2019 to 2020 and Senior Medical Director at Genentech, Inc. from 2014 to 2019.
Education includes a doctorate from The Salk Institute for Biological Studies, an undergraduate degree from Harvard University, and a doctorate from the University of California San Diego.

Known holdings in public companies

CompanyDateNumber of sharesValuationValuation date
31/12/2025 0 ( -.--% ) - $ 31/05/2026

Stina Singel active positions

CompaniesPositionStart
ASCENDIS PHARMA A/S Chief Tech/Sci/R&D Officer 01/05/2020

Former positions of Stina Singel

CompaniesPositionEnd
NEKTAR THERAPEUTICS Corporate Officer/Principal 01/05/2020
Chief Tech/Sci/R&D Officer 01/04/2019
See the detail of Stina Singel's experience

Training of Stina Singel

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

Connections

73

1st degree connections

6

1st degree companies

Male

Female

Members of the board

Executives

Linked companies

Private companies6

Health Technology

Health Technology

Consumer Services

Consumer Services

Consumer Services

Health Technology